Related references
Note: Only part of the references are listed.Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection&IT In Vitro&IT and in a Mouse Model
James Duehr et al.
MSPHERE (2018)
Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity
Lalita Priyamvada et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Antibody-based assay discriminates Zika virus infection from other flaviviruses
Angel Balmaseda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Susana V. Bardina et al.
SCIENCE (2017)
Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barre Syndrome: Systematic Review
Fabienne Krauer et al.
PLOS MEDICINE (2017)
A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses
Shashank Tripathi et al.
PLOS PATHOGENS (2017)
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
Aaron C. Brault et al.
SCIENTIFIC REPORTS (2017)
Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests
Wen-Yang Tsai et al.
CLINICAL INFECTIOUS DISEASES (2017)
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Davide F. Robbiani et al.
CELL (2017)
Structural Basis of Zika Virus-Specific Antibody Protection
Haiyan Zhao et al.
CELL (2016)
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Carole J. Henry Dunand et al.
CELL HOST & MICROBE (2016)
Refined protocol for generating monoclonal antibodies from single human and murine B cells
Irvin Y. Ho et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study
Simon Cauchemez et al.
LANCET (2016)
Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
Van-Mai Cao-Lormeau et al.
LANCET (2016)
Zika Virus Associated with Microcephaly
Jernej Mlakar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
Tilman Schlothauer et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
Neil M. Ferguson et al.
SCIENCE (2016)
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
Karin Stettler et al.
SCIENCE (2016)
Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus
Qihui Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Protective and immunological behavior of chimeric yellow fever dengue vaccine
Scott B. Halstead et al.
VACCINE (2016)
Flavivirus NS1: a multifaceted enigmatic viral protein
Meghana Rastogi et al.
VIROLOGY JOURNAL (2016)
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype
Kimberly A. Dowd et al.
CELL REPORTS (2016)
Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
P. Robert Beatty et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations
Omid Vafa et al.
METHODS (2014)
Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1
Shu-Wen Wan et al.
PLOS ONE (2014)
Control of acute dengue virus infection by natural killer cells
Caroline Petitdemangew et al.
FRONTIERS IN IMMUNOLOGY (2014)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells
Venkatramana D. Krishna et al.
JOURNAL OF VIROLOGY (2009)
Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
Kenneth Smith et al.
NATURE PROTOCOLS (2009)
Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E
Panisadee Avirutnan et al.
PLOS PATHOGENS (2007)
Antibody recognition of cell surface-associated NS1 triggers Fc-γ receptor-mediated phagocytosis and clearance of West Nile virus-infected cells
Kyung Min Chung et al.
JOURNAL OF VIROLOGY (2007)
Prospects for a dengue virus vaccine
Stephen S. Whitehead et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc γ receptor-dependent and -independent mechanisms
KM Chung et al.
JOURNAL OF VIROLOGY (2006)
Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence
SM Costa et al.
VACCINE (2006)
Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1
M Hezareh et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
